MECHANISMS OF ACTIONS OF ALCOHOL AND OMEGA3 FATTY ACIDS
MECHANISMS OF ACTIONS OF ALCOHOL AND OMEGA3 FATTY ACIDS
批准号:
2044311
负责人:
RAJ M LAKSHMAN
金额:
$12.12万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-12-01 至 1999-07-31
关键词:
alcoholism /alcohol abuse apolipoproteins blood lipoprotein metabolism chylomicrons dietary lipid enzyme activity fatty acid biosynthesis fatty liver gel electrophoresis high density lipoproteins human subject hyperlipidemia ion exchange chromatography laboratory rat lipid metabolism messenger RNA nutrition related tag omega 3 fatty acid posttranslational modifications sialyltransferases toxicology triglycerides very low density lipoprotein
中文摘要
申请人摘要:血浆载脂蛋白E(ApoE)是一种糖蛋白
在“反向胆固醇运输”(RCT)中起重要作用的是什么?
高密度脂蛋白的功能,即(一)从外周组织中去除胆固醇
和/或(Ii)将其输送到肝脏。值得注意的是,乙醇减少了
血浆高密度脂蛋白-载脂蛋白E,而omega3-脂肪酸阻止了这种下降。
我们的初步工作表明,人类血浆高密度脂蛋白-载脂蛋白E也降低了
酗酒者。我们进一步表明,慢性乙醇抑制肝脏
ApoE唾液酸化。载脂蛋白E唾液酸缺乏可能影响其
与高密度脂蛋白相关。反过来,从高密度脂蛋白中失去载脂蛋白E可能会损害其
RCT功能。因此,确认载脂蛋白E是否
高密度脂蛋白的浓度和载脂蛋白E的唾液酸含量
然后展示这些变化是如何影响高密度脂蛋白代谢和
功能。这项研究的90%将利用人类,只有其余的
将使用大鼠:人类研究:载脂蛋白E和高密度脂蛋白将来自人类血清
酗酒者、非酗酒者和非酗酒者。具体问题
载脂蛋白E中唾液酸缺乏的程度是否影响(I)
载脂蛋白E与高密度脂蛋白的关系及(Ii)载脂蛋白E与高密度脂蛋白的解离
高密度脂蛋白-载脂蛋白E与胆固醇的关系。三、载脂蛋白E的损失
来自高密度脂蛋白影响其从外周血中清除胆固醇的能力
纸巾?与非酗酒者相比,人类酗酒者是否有所减少:
高密度脂蛋白中载脂蛋白E的浓度?五、高密度脂蛋白-载脂蛋白E中唾液酸含量
高密度脂蛋白从外周组织中去除胆固醇的能力
人类巨噬细胞?vii.高密度脂蛋白将胆固醇输送到肝脏的能力
人HepG2肝细胞大鼠研究:载脂蛋白E唾液酸化是否在
以上是硬件描述语言的重要方面,同样重要的是确定
肝脏载脂蛋白E的翻译后修饰。这可以
只能在老鼠这样的实验动物身上进行。同样,如果omega3-
脂肪酸确实纠正了乙醇引起的上述缺陷,它更简单
而且测试它们对高密度脂蛋白-载脂蛋白E功能的影响所需的时间更短
老鼠比人类还多。因此,提出的问题是什么是
乙醇和欧米茄3-脂肪酸对VIII.的影响
载脂蛋白E在亚细胞水平的翻译后修饰?IX.
抑制肝唾液酸转移酶活性的机制是什么?
具体地说,乙醇是否抑制唾液酸转移酶的合成?
并通过下调其肝脏的mRNA水平?
英文摘要
APPLICANT'S ABSTRACT: Plasma apolipoprotein E (apoE) is a glycoprotein
which plays important roles in "Reverse Cholesterol Transport" (RCT)
functions of HDL, viz., (i) cholesterol removal from peripheral tissues
and/or (ii) its delivery to the liver. Significantly, ethanol decreased
plasma HDL apoE, whereas omega3-fatty acids prevented this decrease.
Our preliminary work shows that plasma HDL apoE is also reduced in human
alcoholics. We have further shown that chronic ethanol inhibits hepatic
sialation of apoE. Sialic acid deficiency in apoE may affect its
association with HDL. In turn, the loss of apoE from HDL may impair its
RCT functions. Therefore, it is important to confirm whether apoE
concentration in HDL and sialic acid content of apoE are reduced in
alcoholics and then show how these changes affect HDL metabolism and
functions. 90% of the study will utilize humans and only the remainder
will use rats:Human Study: ApoE and HDL will be from sera of human
alcoholics and non-alcoholics and non-alcoholics. The specific questions
are: Does the degree of sialic acid deficiency in apoE affect (I) the
association of apoE with HDL and (II) dissociation of apoE from HDL &
association of HDL- apoE with cholesterol. III. does the loss of apoE
from HDL affect its ability to remove cholesterol from peripheral
tissues? Do human alcoholics compared to non-alcoholics have decreased:
IV. concentration of apoE in HDL? V. sialic acid content of HDL-apoE?
VI. HDL ability to remove cholesterol from the peripheral tissues using
human macrophages?VII. HDL ability to deliver cholesterol to liver using
the human HepG2 liver cells?Rat Study: If apoE sialation is crucial in
the above important aspects of HDL it is equally important to determine
the post-translational modifications of apoE in the liver. This can
only be done in experimental animals like rats.Similarly, if omega3-
fatty acids do correct the above defects caused by ethanol it is simpler
and less time consuming to test their effects on HDL-apoE functions in
rats than in humans. Thus, the questions asked are what are the
influences of ethanol and omega3-fatty acids on: VIII. the
posttranslational modifications of apoE at the subcellular level? IX.
the mechanism of inhibition of hepatic sialyltransferase activity?
Specifically, does ethanol inhibit the synthesis of sialyltransferase
and by down regulation of its hepatic mRNA levels?
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ANTI INFLAMMATORY AND ANTIFIBROTIC ACTIONS OF THYMOSIN BETA 4 IN ALD
-
批准号:8854003
-
项目类别:
-
资助金额:$17.57万
-
财政年份:2014
-
负责人:RAJ M LAKSHMAN
-
依托单位:
ANTI INFLAMMATORY AND ANTIFIBROTIC ACTIONS OF THYMOSIN BETA 4 IN ALD
-
批准号:8609964
-
项目类别:
-
资助金额:$14.96万
-
财政年份:2014
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Novel Modulators of Alcohol Induced Metabolic and Liver Injury
-
批准号:8724156
-
项目类别:
-
资助金额:$10.6万
-
财政年份:2013
-
负责人:RAJ M LAKSHMAN
-
依托单位:
NOVEL MODULATORS OF ALCOHOL INDUCED METABOLIC AND LIVER INJURY
-
批准号:8307287
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2011
-
负责人:RAJ M LAKSHMAN
-
依托单位:
NOVEL MODULATORS OF ALCOHOL INDUCED METABOLIC AND LIVER INJURY
-
批准号:8504896
-
项目类别:
-
资助金额:$27.83万
-
财政年份:2011
-
负责人:RAJ M LAKSHMAN
-
依托单位:
NOVEL MODULATORS OF ALCOHOL INDUCED METABOLIC AND LIVER INJURY
-
批准号:8702054
-
项目类别:
-
资助金额:$39.31万
-
财政年份:2011
-
负责人:RAJ M LAKSHMAN
-
依托单位:
NOVEL MODULATORS OF ALCOHOL INDUCED METABOLIC AND LIVER INJURY
-
批准号:8460995
-
项目类别:
-
资助金额:$3.15万
-
财政年份:2011
-
负责人:RAJ M LAKSHMAN
-
依托单位:
NOVEL MODULATORS OF ALCOHOL INDUCED METABOLIC AND LIVER INJURY
-
批准号:8203160
-
项目类别:
-
资助金额:$26.78万
-
财政年份:2011
-
负责人:RAJ M LAKSHMAN
-
依托单位:
NOVEL MODULATORS OF ALCOHOL INDUCED METABOLIC AND LIVER INJURY
-
批准号:8900880
-
项目类别:
-
资助金额:$45.4万
-
财政年份:2011
-
负责人:RAJ M LAKSHMAN
-
依托单位:
BRAIN SOCS3 AND PTP1B-ADIPOSE LEPTIN FEEDBACK AXIS IN ALCOHOLIC HEPATOSTEATOSIS
-
批准号:8144479
-
项目类别:
-
资助金额:$15.14万
-
财政年份:2010
-
负责人:RAJ M LAKSHMAN
-
依托单位:
BRAIN SOCS3 AND PTP1B-ADIPOSE LEPTIN FEEDBACK AXIS IN ALCOHOLIC HEPATOSTEATOSIS
-
批准号:8065693
-
项目类别:
-
资助金额:$18.9万
-
财政年份:2010
-
负责人:RAJ M LAKSHMAN
-
依托单位:
MODULATORS OF ALCOHOLIC LIPIDEMIA & STEATOSIS:KEY ROLE OF SCAVENGER RECEPTOR B I
-
批准号:7926902
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2009
-
负责人:RAJ M LAKSHMAN
-
依托单位:
ACTION OF ALCOHOL/QUERCETIN ON ANTI-ATHEROGENIC FACTOR
-
批准号:7146990
-
项目类别:
-
资助金额:$18.11万
-
财政年份:2006
-
负责人:RAJ M LAKSHMAN
-
依托单位:
ACTION OF ALCOHOL & QUERCETIN ON ANTI-ATHEROGENIC FACTORS & ATHEROGENESIS
-
批准号:7267983
-
项目类别:
-
资助金额:$17.59万
-
财政年份:2006
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
-
批准号:6542331
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2002
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
-
批准号:6917377
-
项目类别:
-
资助金额:$6.28万
-
财政年份:2002
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
-
批准号:6744843
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2002
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
-
批准号:6890039
-
项目类别:
-
资助金额:$34.82万
-
财政年份:2002
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
-
批准号:7623633
-
项目类别:
-
资助金额:$3.15万
-
财政年份:2002
-
负责人:RAJ M LAKSHMAN
-
依托单位:
Light & Heavy Alcohol, Paraoxonase & Oxidized LDL Status
-
批准号:7057373
-
项目类别:
-
资助金额:$34.35万
-
财政年份:2002
-
负责人:RAJ M LAKSHMAN
-
依托单位:
海外基金